CellVoyant
Healthcare AI
cell therapy development, predictive cell analytics, live-cell imaging, bioprocess optimization
Seed
CellVoyant is an AI-first biotechnology company focused on accelerating the development of cell-based therapies using live-cell imaging, computer vision, and predictive AI to optimize stem cell differentiation and bioprocess workflows. Its products include FateView and FateDrive/FateSim-style predictive and optimization tools for non-destructive cell analysis and adaptive process control.
Company Details
- Website
- cellvoyant.com
- Headquarters
- Bristol, England, United Kingdom
- Founded
- 2021
- Funding
- ~£7.6M seed (about $10M); some databases report total funding around $9.6M–$10.3M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring